Electroacupuncture Therapy for Treating Postherpetic Neuralgia
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Postherpetic neuralgia (PHN) has a high incidence rate and severely impact on quality of life
and health care costs, interfering with physical, emotional and social functioning of
affected patients. Current therapeutic options for PHN mainly include analgetic and local
anaesthesia for selective nerve blockade. Nevertheless, the efficacy of analgetic is always
limited by inevitable side effects, in which patients have poor compliance. Moreover, for
some most suffering patients, the control of pain is often unsatisfactory despite the
administration of complex combinations. As a non-pharmarceutical therapy, acupuncture is
widely use for a wide range of pain conditions. Thus, it might be an alternative treatment
for PHN. The aim of this multicenter randomized controlled trial is to investigate the
efficacy and safety of electroacupuncture therapy in patients with postherpetic neuralgia.
Phase:
N/A
Details
Lead Sponsor:
The Third Affiliated hospital of Zhejiang Chinese Medical University
Collaborators:
Lishui Hospital of Traditional Chinese Medicine The First Affiliated Hospital of Zhejiang Chinese Medical University Zhejiang Provincial Tongde Hospital